We again observed that GSK3B inhibition significantly reduced the wt53BP1 SB28 cell survival fraction (Figure 11C) and inhibited tumor growth, measured by tumor volume and weight at day 26 following PARPi (Figure 11, D–F, and Supplemental Figure 10). This evidence concerns the gene GSK3B and neoplasm.